Advances in cancer biology and sequencing technology have enabled the selection of
targeted and more effective treatments for individual patients with various types of solid …

Human epidermal growth factor receptor 2 (HER2) overexpression is increasingly
recognized as a frequent molecular abnormality in gastric and gastroesophageal cancer …

Purpose In Asian countries, paclitaxel once per week is used as second-line treatment in
advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2) …

The year 2007 marks exactly two decades since Human Epidermal Growth Factor Receptor-
2 (HER2) was functionally implicated in the pathogenesis of human breast cancer. This …

Aims: Human epidermal growth factor receptor 2 (HER2) overexpression/amplification is
implicated in the development of various solid tumour types. Validated methods and scoring …

Human epidermal growth factor receptor 2 (HER2) is involved in the pathogenesis and poor
outcomes of several types of cancer, including advanced gastric and gastroesophageal …

Trastuzumab-based therapy has been shown to confer overall survival benefit in HER2-
positive patients with advanced gastric cancer in a large multicentric trial (ToGA study) …

Background & Aims Our goal was to develop an initial study for the proof of concept whereby
gastric cancer organoids are used as an approach to predict the tumor response in …

Although gastric cancer is quite common in Korea, the treatment outcome is relatively
favorable compared to those in western countries. However, there are currently no Korean …

Gastric cancer is the third leading cause of cancer mortality worldwide. As surgery is the only
curative treatment strategy and conventional chemotherapy has shown limited efficacy-with …